ArticleInternational journal of clinical oncology2025
Risk of severe infections in patients with triple-negative breast cancer treated with atezolizumab plus nab-paclitaxel: a real-world, postmarketing database study in Japan.
Akinori Yuri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.